• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (GFO) LUTONIX 035 DRUG COATED BALLOON PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (GFO) LUTONIX 035 DRUG COATED BALLOON PTA CATHETER Back to Search Results
Model Number 9004
Device Problems Retraction Problem (1536); Material Rupture (1546); Material Split, Cut or Torn (4008)
Patient Problem Foreign Body In Patient (2687)
Event Date 03/21/2019
Event Type  Injury  
Manufacturer Narrative
Analysis/device evaluation: upon receipt, visual examination of the catheter revealed multiple kinks along the length of the catheter.Further inspection noted the distal end of the balloon portion was returned with the device.Examination of the balloon material noted it was torn with jagged edges and surface abrasions at the initiation of the torn balloon material.The inner lumen is severely stretched and the proximal marker band is displaced and damaged in a slight oval shape.The distal end of the returned inner lumen is torn and the edges are jagged.There is shearing damage, proximal to the distal end of the inner lumen.Due to the returned condition of the device performance testing was unable to be performed.A lot history review revealed this is the only complaint associated with allegations of material rupture with retraction issues resulting in device separation for this lot.A device history record (dhr) review was performed and noted the device was manufactured to specification prior to being released for distribution.Conclusion: returned product analysis confirmed the reported material rupture and difficulty re-sheathing the balloon.Based on the information provided and analysis results, the material rupture was likely caused by treating a calcified non-target lesion in the common iliac artery.The force applied to the catheter during removal though the introducer sheath likely contributed to the balloon material separating from the catheter.There was nothing found to indicate there was a design, manufacturing or component anomaly which would have caused or contributed to this event.If additional information becomes available, a supplement report will be submitted with all relevant information.
 
Event Description
It was reported a lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter allegedly ruptured on its second inflation at 14 atmospheres (atms) while treating a non-target lesion in the common iliac.The health care professional (hcp) used a contralateral approach with a 7 french ansel introducer sheath over an unknown 035 guidewire to treat the target lesion in the superficial femoral artery (sfa).The hcp reportedly used a hawk one atherectomy over an 014 guidewire to prepare the target lesion in the sfa.Reportedly, the 014 guidewire was exchanged for an 035 guidewire in preparation to advance the lutonix 035 catheter.The hcp then reached the target lesion with the lutonix dcb and allegedly inflated the device to 8 atms.After successful treatment of the sfa, the hcp pulled the lutonix dcb to a stenosed region of the common iliac artery and inflated the lutonix dcb to 14 atms.Reportedly, the lutonix dcb ruptured during this inflation attempt.Upon attempts to remove the device, reportedly the balloon would not re-sheath, resulting in the balloon portion becoming stuck in the introducer sheath.Eventually, the hcp tore the balloon and the balloon portion became lodged in the common iliac artery over the aortic bifurcation.The hcp obtained an additional access from the opposite side of the original patient access.The balloon portion was reportedly fixated to the artery wall with two kissing stents which completed the procedure.The lutonix dcb was returned for evaluation.No further adverse patient outcomes were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035 DRUG COATED BALLOON PTA CATHETER
Type of Device
DRUG COATED BALLOON PTA CATHETER
Manufacturer (Section D)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
mike gaffney
9409 science center dr
new hope, MN 55428
7634458639
MDR Report Key8531615
MDR Text Key142493778
Report Number3006513822-2019-00060
Device Sequence Number1
Product Code ONU
UDI-Device Identifier00801741123245
UDI-Public(01)00801741123245
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,other
Reporter Occupation Physician
Type of Report Initial
Report Date 04/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/19/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/15/2020
Device Model Number9004
Device Catalogue NumberLX3513051505F
Device Lot NumberGFBY1837
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/09/2019
Is the Reporter a Health Professional? Yes
Event Location Hospital
Date Manufacturer Received03/22/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/20/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age86 YR
Patient Weight71
-
-